HomeComparePRMDX vs JNJ

PRMDX vs JNJ: Dividend Comparison 2026

PRMDX yields 2.57% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PRMDX wins by $3.5K in total portfolio value
10 years
PRMDX
PRMDX
● Live price
2.57%
Share price
$5.14
Annual div
$0.13
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$23.5K
Annual income
$303.61
Full PRMDX calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — PRMDX vs JNJ

📍 PRMDX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPRMDXJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PRMDX + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PRMDX pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PRMDX
Annual income on $10K today (after 15% tax)
$218.60/yr
After 10yr DRIP, annual income (after tax)
$258.07/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, JNJ beats the other by $445.54/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PRMDX + JNJ for your $10,000?

PRMDX: 50%JNJ: 50%
100% JNJ50/50100% PRMDX
Portfolio after 10yr
$21.8K
Annual income
$565.70/yr
Blended yield
2.60%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

PRMDX
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PRMDX buys
0
JNJ buys
0
No recent congressional trades found for PRMDX or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPRMDXJNJ
Forward yield2.57%3.36%
Annual dividend / share$0.13$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$23.5K$20.0K
Annual income after 10y$303.61$827.78
Total dividends collected$2.8K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: PRMDX vs JNJ ($10,000, DRIP)

YearPRMDX PortfolioPRMDX Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$10,957$257.18$10,676$355.77+$281.00PRMDX
2$11,988$263.36$11,407$389.39+$581.00PRMDX
3$13,096$269.28$12,198$426.53+$898.00PRMDX
4$14,288$274.93$13,056$467.62+$1.2KPRMDX
5$15,568$280.32$13,987$513.12+$1.6KPRMDX
6$16,943$285.46$14,998$563.56+$1.9KPRMDX
7$18,420$290.36$16,098$619.52+$2.3KPRMDX
8$20,004$295.01$17,295$681.69+$2.7KPRMDX
9$21,704$299.42$18,599$750.82+$3.1KPRMDX
10$23,527$303.61$20,022$827.78+$3.5KPRMDX

PRMDX vs JNJ: Complete Analysis 2026

PRMDXStock

The fund will invest so that, under normal market conditions, at least 80% of its net assets (including any borrowings for investment purposes) are invested in bonds that pay interest exempt from federal and Maryland state and local income taxes, and at least 80% of the fund's income is expected to be exempt from federal and Maryland state and local income taxes. It is non-diversified.

Full PRMDX Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this PRMDX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PRMDX vs SCHDPRMDX vs JEPIPRMDX vs OPRMDX vs KOPRMDX vs MAINPRMDX vs ABBVPRMDX vs MRKPRMDX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.